LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Vemurafenib | 10 | uM | LJP5 | 3 | C13 | 72 | hr | 513 | 2077 | 10483 | 0.1981 | 0.3787 |
MCF 10A | Enzastaurin | 0.04 | uM | LJP5 | 1 | D18 | 72 | hr | 513 | 10163 | 10254 | 0.9911 | 0.9958 |
MCF 10A | Enzastaurin | 0.04 | uM | LJP5 | 2 | D18 | 72 | hr | 513 | 9719 | 10349 | 0.9391 | 0.9712 |
MCF 10A | Enzastaurin | 0.04 | uM | LJP5 | 3 | D18 | 72 | hr | 513 | 10927 | 10483 | 1.0423 | 1.0191 |
MCF 10A | Enzastaurin | 0.12 | uM | LJP5 | 1 | D17 | 72 | hr | 513 | 9984 | 10254 | 0.9736 | 0.9877 |
MCF 10A | Enzastaurin | 0.12 | uM | LJP5 | 2 | D17 | 72 | hr | 513 | 9588 | 10349 | 0.9264 | 0.9650 |
MCF 10A | Enzastaurin | 0.12 | uM | LJP5 | 3 | D17 | 72 | hr | 513 | 10582 | 10483 | 1.0094 | 1.0043 |
MCF 10A | Enzastaurin | 0.37 | uM | LJP5 | 1 | D16 | 72 | hr | 513 | 9503 | 10254 | 0.9267 | 0.9651 |
MCF 10A | Enzastaurin | 0.37 | uM | LJP5 | 2 | D16 | 72 | hr | 513 | 10054 | 10349 | 0.9714 | 0.9867 |
MCF 10A | Enzastaurin | 0.37 | uM | LJP5 | 3 | D16 | 72 | hr | 513 | 10384 | 10483 | 0.9905 | 0.9956 |
MCF 10A | Enzastaurin | 1.11 | uM | LJP5 | 1 | D15 | 72 | hr | 513 | 9451 | 10254 | 0.9216 | 0.9626 |
MCF 10A | Enzastaurin | 1.11 | uM | LJP5 | 2 | D15 | 72 | hr | 513 | 9818 | 10349 | 0.9486 | 0.9758 |
MCF 10A | Enzastaurin | 1.11 | uM | LJP5 | 3 | D15 | 72 | hr | 513 | 10783 | 10483 | 1.0286 | 1.0130 |
MCF 10A | Enzastaurin | 3.33 | uM | LJP5 | 1 | D14 | 72 | hr | 513 | 9129 | 10254 | 0.8902 | 0.9469 |
MCF 10A | Enzastaurin | 3.33 | uM | LJP5 | 2 | D14 | 72 | hr | 513 | 8367 | 10349 | 0.8084 | 0.9042 |
MCF 10A | Enzastaurin | 3.33 | uM | LJP5 | 3 | D14 | 72 | hr | 513 | 9942 | 10483 | 0.9483 | 0.9758 |
MCF 10A | Enzastaurin | 10 | uM | LJP5 | 1 | D13 | 72 | hr | 513 | 7265 | 10254 | 0.7085 | 0.8466 |
MCF 10A | Enzastaurin | 10 | uM | LJP5 | 2 | D13 | 72 | hr | 513 | 7708 | 10349 | 0.7448 | 0.8685 |
MCF 10A | Enzastaurin | 10 | uM | LJP5 | 3 | D13 | 72 | hr | 513 | 7904 | 10483 | 0.7539 | 0.8743 |
MCF 10A | Palbociclib | 0.04 | uM | LJP6 | 1 | E18 | 72 | hr | 513 | 7723 | 10537 | 0.7329 | 0.8624 |
MCF 10A | Palbociclib | 0.04 | uM | LJP6 | 2 | E18 | 72 | hr | 513 | 7721 | 10386 | 0.7433 | 0.8678 |
MCF 10A | Palbociclib | 0.04 | uM | LJP6 | 3 | E18 | 72 | hr | 513 | 7836 | 10494 | 0.7467 | 0.8702 |
MCF 10A | Palbociclib | 0.12 | uM | LJP6 | 1 | E17 | 72 | hr | 513 | 6208 | 10537 | 0.5891 | 0.7714 |
MCF 10A | Palbociclib | 0.12 | uM | LJP6 | 2 | E17 | 72 | hr | 513 | 6056 | 10386 | 0.5830 | 0.7662 |
MCF 10A | Palbociclib | 0.12 | uM | LJP6 | 3 | E17 | 72 | hr | 513 | 6492 | 10494 | 0.6186 | 0.7911 |